Evidence mapPaperPMID 42328893Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2026

Proanthocyanidin-Rich Cranberry Extract Lowers Glycemia in Established Obesity by Delaying Glucose Absorption.

Sarra Beji, Mathilde Mouchiroud, Laura Tribouillard, Bernie Efole, Lia Perazza, Léa Favereaux, Audrey Poirier, Wandy Idris, Yves Gélinas, Thibault V Varin and 7 more

Abstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Sarra BejiQuebec Heart and Lung Institute, Quebec City, Quebec, Canada.
Mathilde MouchiroudQuebec Heart and Lung Institute, Quebec City, Quebec, Canada.
Laura TribouillardQuebec Heart and Lung Institute, Quebec City, Quebec, Canada.
Bernie EfoleQuebec Heart and Lung Institute, Quebec City, Quebec, Canada.
Lia PerazzaQuebec Heart and Lung Institute, Quebec City, Quebec, Canada.
Léa FavereauxQuebec Heart and Lung Institute, Quebec City, Quebec, Canada.
Audrey PoirierQuebec Heart and Lung Institute, Quebec City, Quebec, Canada.
Wandy IdrisQuebec Heart and Lung Institute, Quebec City, Quebec, Canada.
Yves GélinasQuebec Heart and Lung Institute, Quebec City, Quebec, Canada.
Thibault V VarinQuebec Heart and Lung Institute, Quebec City, Quebec, Canada.
Carole RovèreInstitut de Pharmacologie Moléculaire et Cellulaire, Université Côte d'Azur, CNRS, Inserm, Valbonne, France.
Fernando Forato AnhêQuebec Heart and Lung Institute, Quebec City, Quebec, Canada.ORCID https://orcid.org/0000-0003-1543-4154
Frédéric PicardQuebec Heart and Lung Institute, Quebec City, Quebec, Canada.
Mathieu LaplanteQuebec Heart and Lung Institute, Quebec City, Quebec, Canada.
André MaretteQuebec Heart and Lung Institute, Quebec City, Quebec, Canada.ORCID https://orcid.org/0000-0003-3950-5973
Andréanne MichaudQuebec Heart and Lung Institute, Quebec City, Quebec, Canada.
Alexandre CaronQuebec Heart and Lung Institute, Quebec City, Quebec, Canada.ORCID https://orcid.org/0000-0001-6939-6136

Funding

Canada Research Chairs (CRC)UL | Sentinelle Nord, Université Laval (Sentinel North)
6 · The paper itself

Abstract

Dietary polyphenols, including proanthocyanidins, have emerged as potential modulators of metabolic health. Evidence supports benefits on glucose and hepatic metabolism in diet-induced obesity. However, reported effects vary widely across polyphenol sources and experimental design, and the key physiological mediators of benefit in established obesity remain incompletely defined. Moreover, ambient temperature, a key determinant of metabolic phenotype that may influence therapeutic responses, is rarely considered. Here we aim to determine the metabolic effects and mechanisms of action of a proanthocyanidin-rich cranberry extract (PRCE) in established diet-induced obesity under cold (10°C) and thermoneutral (30°C) housing conditions. Male mice with established obesity were supplemented with PRCE or vehicle while housed at 10°C or 30°C. Metabolic phenotyping included body composition, glucose homeostasis, intestinal carbohydrate digestion and glucose absorption, circadian profiling of peripheral and central clocks, and gut microbiota analysis. PRCE supplementation significantly improved glycemia and glucose tolerance independently of temperature, without altering body weight, adiposity, thermogenic gene expression, or circadian expression of clock genes centrally and peripherally. Mechanistically, PRCE inhibited α-amylase activity and delayed early intestinal glucose absorption. These effects were accompanied by selective remodeling of the gut microbiota, including increased abundance of Akkermansia muciniphila. We conclude that PRCE improves glucose homeostasis in established obesity through intestinal mechanisms involving reduced carbohydrate digestion, delayed glucose absorption, and selective remodeling of the gut microbiota.

Indexed as

Blood GlucoseGlucoseObesityPlant ExtractsProanthocyanidinsVaccinium macrocarponAnimalsGastrointestinal MicrobiomeIntestinal AbsorptionMaleMiceMice, Inbred C57BLBlood GlucoseGlucosePlant ExtractsproanthocyanidinProanthocyanidinsambient temperatureglucose absorptionglycemic controlgut microbiotaobesityproanthocyanidins

Identifiers

PMID42328893
PMCPMC13285252

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.